Facility upgrades support clinical-grade manufacturing of Bracco’s microbubble-based cell selection and activation technology GMP readiness expected mid-2027 MARCH 31, 2026, Princeton, ...
Officials at Caring Cross emphasize that the organization is dedicated to ensuring the global affordability of advanced therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results